All lobbying filings

FIERCE GOVERNMENT RELATIONS

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) · Trade Organization for Generic Drug Manufacturers and Distributers

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Oct 16, 2025

Official filing document

Bills named in this filing 7

S 1041
Affordable Prescriptions for Patients Act
S 43
Skinny Labels, Big Savings Act
S 1302
Increasing Transparency in Generic Drug Applications Act
S 1954
Biosimilar Red Tape Elimination Act
S 1414
Expedited Access to Biosimilars Act
S 2296
National Defense Authorization Act for Fiscal Year 2026
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…

Lobbying activity 1

Pharmacy

Supply Chain, Drug Shortages, Tariffs, Patent Thickets, S.1041 - Affordable Prescriptions for Patients Act, S.43 - Skinny Labels - Big Savings Act, S.1302 - A Bill to Provide for Increased Transparency in Generic Drug Applications, S.1954- Biosimilar Red Tape Reduction Act, S.1414 - Expected Access to Biosimilars Act, S.2296 - National Defense Authorization Act for FY 2026, and H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026, Generic Drugs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.